전문 번역가, 번역 회사, 웹 페이지 및 자유롭게 사용할 수 있는 번역 저장소 등을 활용합니다.
i dessa tre 6- veckorsstudier erhölls följande effektresultat vid studiens slut:
in these three 6-week studies, the efficacy results at endpoint were as follows:
마지막 업데이트: 2012-04-11
사용 빈도: 2
품질:
panretin har undersökts i två 12- veckorsstudier med sammanlagt 402 patienter med kaposis sarkom.
panretin has been examined in two 12-week studies in patients with kaposi’ s sarcoma, involving a total of 402 patients, where the effectiveness of panretin was compared to that of placebo (a dummy treatment, in this instance the gel without the active substance).
마지막 업데이트: 2011-10-23
사용 빈도: 1
품질:
elektrokardiogram togs under 12- veckorsstudier på 755 duloxetinbehandlade patienter med ansträngningsinkontinens och 779 placebobehandlade patienter.
electrocardiograms were obtained from 755 duloxetine-treated patients with sui and 779 placebo- treated patients in 12-week clinical trials.
마지막 업데이트: 2012-04-11
사용 빈도: 4
품질:
i dessa 52-veckorsstudier behandlades patienterna i 12 veckor, följt av 40 veckor utan behandling.
in these 52 week duration studies, patients received treatment for 12 weeks, followed by a 40 week non-treatment phase.
마지막 업데이트: 2017-04-26
사용 빈도: 4
품질:
ariclaim har undersökts i två 12-veckorsstudier på 809 vuxna diabetespatienter som hade haft smärtor varje dag i minst sex månader.
ariclaim has been studied in two 12-week studies in 809 diabetic adults who had had pain every day for at least six months.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
när det gällde behandling av neuropatisk smärta vid diabetes undersöktes ariclaim i två 12- veckorsstudier på 809 vuxna diabetespatienter som haft smärta varje dag i minst sex månader.
for the treatment of diabetic neuropathic pain, ariclaim has been studied in two 12-week studies in 809 diabetic adults who had had pain every day for at least six months.
마지막 업데이트: 2012-04-11
사용 빈도: 1
품질:
två dubbelblinda, placebokontrollerade 24-veckorsstudier utfördes för att utvärdera effekten och säkerheten med saxagliptin som monoterapi till patienter med typ 2-diabetes.
two double-blind, placebo-controlled studies of 24-week duration were conducted to evaluate the efficacy and safety of saxagliptin monotherapy in patients with type 2 diabetes.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
kliniska biverkningar hos patienter med kronisk hepatit b, som behandlats med telbivudin 600 mg i de sammanslagna 104- veckorsstudierna nv- 02b- 007 globe och nv- 02b- 015 *
clinical adverse reactions in patients with chronic hepatitis b, treated with telbivudine 600 mg in the pooled 104-week nv-02b-007 (globe) and nv-02b-015 studies *
마지막 업데이트: 2012-04-11
사용 빈도: 4
품질: